Canada grants bioAffinity Technologies new patent that protects its proprietary technology that powers its flagship product, CyPath® Lung ...

Looking for Clues Many lung cancers in nonsmokers have no known cause and are discovered only by chance. That was the case for Sandra Liu, 59, who lives in New Jersey. Ms.

Scientists have uncovered a molecular "on–off" switch that helps lung adenocarcinoma—the most common form of lung cancer—grow and spread. The discovery pinpoints the protein calcyclin ...

Visible on chest CT scans, post-COVID-19 residual lung abnormalities, which affect up to 50% of patients who have had an infection requiring hospitalization, may be associated with persistent or ...

Air pollution may steer lung cells toward cancer ­— even in people who’ve never smoked a cigarette. People living in high pollution areas may rack up DNA glitches that trigger lung cancer ...

AirLife and Vyaire are recalling specific infant breathing support systems due to a potentially dangerous defect that could lead to serious injury or death.

An infant breathing system used during ventilation has been recalled, with the FDA warning it could cause serious injury or death if used, according to the FDA website. Airlife and Vyaire are ...

Ex-MMA fighter and Olympic wrestler Ben Askren spoke for the first time since receiving a double lung transplant following a battle with pneumonia.

Case Study: CyPath® Lung Detects Stage 1A Lung Cancer in High-Risk Patient with Inconclusive Imaging bioAffinity Technologies’ noninvasive sputum test revealed early-stage lung cancer when ...

Lung cancer, the second-most common cancer in the U.S., is often associated with smoking — but even those who have never had a cigarette could be at risk of the deadly disease.